CMV

COMMUNIQUÉS West-GlobeNewswire

LiveWorld Releases First-Ever AI Brand Reputation Index for Leading OTC Brands
01/07/2025
Study highlights how AI tools like ChatGPT are shaping reputation and consumer perception of leading OTC brands CAMPBELL, Calif. and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Campbell, California and New York City – [...]
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic
01/07/2025
-- Milestone expands global reach and reinforces commitment to accessible, first-line infertility solutions -- ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator [...]
Inmagene Doses First Patient in the ADAPTIVE Phase 2b Trial of IMG-007, a Nondepleting Anti-OX40 mAb with an Extended Half-life, in Patients with Moderate-to-Severe Atopic Dermatitis
01/07/2025
The ADAPTIVE Phase 2b trial evaluates multiple dose regimens of IMG-007 in patients with moderate-to-severe atopic dermatitis Topline data expected in the fourth quarter of 2026 SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE [...]
Visory Health Wins Gold at the 2025 Digital Health Awards
01/07/2025
Award-winning health tech company brings prescription savings to over 38,700 pharmacies nationwide ESTERO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Visory Health , a leading patient-first health tech prescription [...]
Processa Pharmaceuticals Provides Portfolio and Business Update
01/07/2025
Signed binding term sheet granting Intact Therapeutics an exclusive option to license PCS12852 Continue enrolling patients in Phase 2 study of PCS6422 Strengthened balance sheet with $7M capital infusion VERO BEACH, Fla [...]
Aviv Clinics Partners with Koterra to Expand Veteran Access to Lifesaving TBI and PTSD Treatment
01/07/2025
World-renowned brain treatment center is teaming up with a Tampa-based nonprofit to bring hyperbaric oxygen therapy treatments for Veterans across the country THE VILLAGES, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Every [...]
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right
01/07/2025
MOUNTAIN VIEW, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company that has focused on developing engineered IgM-based therapeutic antibodies, today announced that it [...]
H.H.C. Group Celebrates 30 Years of Industry Leadership in Healthcare Cost Containment
01/07/2025
ROCKVILLE, Md., July 01, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), a leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review [...]
Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
01/07/2025
MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of USD 222 billion over next 10 years Ongoing investment in in-house [...]
GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)
01/07/2025
Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival 2- and 6-week interim safety results [...]
Earth Science Tech, Inc. Qualifies for and Joins New OTCID Tier
01/07/2025
Miami, FL, July 01, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring, optimizing, and scaling high-potential operating businesses [...]
Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants
01/07/2025
SARASOTA, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced [...]
Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio
01/07/2025
Chief Executive Officer (CEO) Christian Kanstrup steps down Chief Scientific Officer Birgitte Rønø appointed interim CEO and search for new CEO has commenced Thomas Schmidt appointed permanent Chief Financial Officer [...]
CytoDyn Announces Encouraging Survival Data in Patients with Metastatic Colorectal Cancer Previously Treated with Leronlimab
01/07/2025
Positive results in patients with advanced mCRC emphasize potential significance of CytoDyn’s ongoing Phase II CRC trial Dr. Benjamin Weinberg to present final results at the ESMO Gastrointestinal Cancers Congress 2025 [...]
Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies
01/07/2025
New law goes into effect on July 1 st authorizing Florida physicians to provide stem cell therapies to their patients for orthopedics, wound care, and pain management FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE [...]
PetMed Express, Inc. Provides Update on Status of Fourth Quarter and FY 2025 Results and Form 10-K Filing
01/07/2025
DELRAY BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today provided an update on the status of its fourth quarter and FY [...]
Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance
01/07/2025
Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral Appliance Treatment LITTLETON, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- Vivos [...]
Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Convertible Notes and Warrants
01/07/2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today [...]
Outlook Therapeutics Appoints Biopharmaceutical Industry and Commercial Leader Bob Jahr as Chief Executive Officer
01/07/2025
Well-established executive with over 20 years of experience building and leading commercial teams across diverse therapeutic markets and geographies Career focused on driving business growth and developing an integrated [...]

Pages